Takashi Komatsu Selected Research

cifenline (cibenzoline)

9/2010	Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery.
2/2009	A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation.
6/2006	Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
4/2003	[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
2/2002	[Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Komatsu Research Topics

Disease

28	Atrial Fibrillation 11/2017 - 02/2002
5	Stroke (Strokes) 08/2016 - 08/2004
4	Cardiac Arrhythmias (Arrythmia) 10/2022 - 09/2003
3	Thromboembolism 01/2014 - 03/2010
3	Ischemic Stroke 01/2014 - 01/2010
2	Heart Diseases (Heart Disease) 08/2017 - 01/2005
2	Hypertension (High Blood Pressure) 01/2013 - 01/2005
2	Heart Failure 01/2013 - 01/2013
2	Tachycardia (Tachyarrhythmias) 02/2009 - 01/2007
2	Atrial Remodeling 07/2008 - 01/2007
1	Cytomegalovirus Infections (Inclusion Disease) 08/2021
1	Infections 08/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2019
1	Sinus Tachycardia 09/2019
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2019
1	Myocardial Infarction 01/2019
1	Viremia 01/2018
1	Turner Syndrome (Turner's Syndrome) 01/2018
1	Blount disease 01/2018
1	Acute Coronary Syndrome 01/2013
1	Myalgia 01/2011
1	Dyslipidemias (Dyslipidemia) 01/2011
1	Hemorrhage 01/2011
1	Disease Progression 03/2010
1	Hyperlipidemias (Hyperlipidemia) 01/2005
1	Diabetes Mellitus 01/2005
1	Latent Infection 12/2004
1	Primary Effusion Lymphoma 12/2002
1	Neoplasms (Cancer) 12/2002

Drug/Important Bio-Agent (IBA)

9	Anti-Arrhythmia AgentsIBA 08/2017 - 12/2005
5	AnticoagulantsIBA 08/2016 - 01/2010
5	cifenline (cibenzoline)IBA 09/2010 - 02/2002
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2010 - 02/2003
4	Amiodarone (Amiodarona)FDA LinkGeneric 01/2011 - 01/2005
3	pilsicainideIBA 08/2017 - 06/2006
3	Warfarin (Coumadin)FDA LinkGeneric 01/2011 - 08/2004
3	Disopyramide (Norpace)FDA LinkGeneric 09/2010 - 04/2003
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
2	AprindineIBA 10/2015 - 04/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011 - 07/2009
2	Atrial Natriuretic Factor (ANF)IBA 02/2009 - 02/2002
1	Neutralizing AntibodiesIBA 08/2021
1	Flecainide (Tambocor)FDA LinkGeneric 08/2017
1	Bepridil (Vascor)FDA Link 10/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2011
1	Atorvastatin (Lipitor)FDA Link 01/2011
1	Indicators and Reagents (Reagents)IBA 02/2009
1	Enalapril FDA LinkGeneric 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 12/2004
1	latency-associated nuclear antigenIBA 12/2004
1	Cholinergic Antagonists (Anticholinergics)IBA 04/2003
1	NucleotidesIBA 12/2002
1	DNA Transposable Elements (Element, IS)IBA 12/2002
1	Proteins (Proteins, Gene)FDA Link 12/2002
1	CatecholaminesIBA 02/2002

Therapy/Procedure

20	Therapeutics 08/2021 - 02/2003
6	Electric Countershock (Cardioversion) 02/2009 - 09/2003
1	Drug Therapy (Chemotherapy) 10/2022
1	Catheter Ablation 09/2019
1	Carotid Endarterectomy 01/2019
1	Osteotomy 01/2018
1	Secondary Prevention 08/2016